(2026). Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: A Korean multicenter study. Journal of Headache and Pain.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Real-world Effectiveness and Safety of CGRP Monoclonal Antibodies in Elderly Migraine Patients: A Korean Multicenter Study."
Journal of Headache and Pain 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Real-world Effectiveness and Safety of CGRP Monoclonal Antibodies in Elderly Migraine Patients: A Korean Multicenter Study."
Journal of Headache and Pain, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.